GMP 合同製造市場：按產品類型、應用、方法、最終用戶、地區劃分——規模、份額、展望、機會分析，2022-2030 年

GMP 蛋白質（大腸桿菌）可能會或可能不會使用無動物工藝生產，具體取決於蛋白質的特性。 重組蛋白是由克隆在支持基因表達和信使 RNA 翻譯的系統中的基因重組 DNA 編碼的蛋白質。 通過重組 DNA 技術對基因進行修飾可能會導致突變蛋白的表達。 在細菌中共表達的蛋白質沒有磷酸化或糖基化等翻譯後修飾。 作為藥物生產和銷售的重組蛋白包括 Humulin、Hematrope、Avonex、Kogenate 和 Pulmozyme。

市場動態

預計在預測期內，市場上產品發布的增加將推動全球 GMP 蛋白（大腸桿菌）合同製造市場的增長。 例如，2022 年 6 月，優質生命科學研究試劑和服務提供商 AMSBIO 宣布推出用於細胞治療應用的 Stem Fit Protein 系列重組蛋白。 Stemfit Protein 系列包括在胰腺、心臟、腎臟、血液和免疫細胞中胚胎幹細胞 (ES) 和誘導多能細胞 (iPS) 的分化中發揮重要作用的重組蛋白。 此外，2021 年 9 月，為生命科學研究提供抗體、免疫試劑盒和重組蛋白的 Aviva System Biology 將推出半訂單 GMP 等級組，供生命科學家進行基礎和臨床前研究。我們宣布推出一個新的替代蛋白質組合。 我們的 Protein on Demand 產品組合包含超過 300,000 種蛋白質，可讓您的研究團隊快速獲得定制蛋白質的中小規模生產。

這項研究的主要特點

• 本報告對全球 GMP 蛋白（大腸桿菌）合同製造市場進行了深入分析，顯示了預測期內（2022-2030 年）的市場規模和復合年增長率 (CAGR%)，其中 2021 年為基準年。報價。
• 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 根據以下參數對全球 GMP 蛋白質（大腸桿菌）合同製造市場的主要參與者進行了介紹 - 公司亮點、產品組合、主要亮點、財務業績和戰略。
• 本研究涵蓋的主要公司包括 Merck & Co., Inc.、Thermo Fisher Scientific Inc.、Abcam plc、GenScript、Biomay AG、SOL GROUP、Proteintech Group, Inc.、Nordmark Pharma GmbH、Sino Biological、 Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc., Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen , ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc., Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd. 和 Enzo Life Sciences, Inc.
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 全球 GMP 蛋白質（大腸桿菌）合同製造市場報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者將能夠通過用於分析全球 GMP 蛋白質（大腸桿菌）合同製造市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 市場概況：按應用分類
  • 市場概況：按方法
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 害蟲分析
• 波特分析
• 主要發展狀況
• 監管場景
• 收購/合同方案
• 品牌映射

第 4 章全球 GMP 蛋白（大腸桿菌）合同製造市場：冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球 GMP 蛋白質（大腸桿菌）合同製造市場：按產品類型，2017-2030

• 細胞因子
• 生長因子
• 酵素
• DNA聚合□
• 蛋白□
• 胰蛋白□
• 核酸□
• IVT□
• 其他
• 荷爾蒙
• 抗原
• 其他

第 6 章全球 GMP 蛋白質（大腸桿菌）合同製造市場：按應用分類，2017-2030

• 基因治療
• 細胞療法

第 7 章全球 GMP 蛋白質（大腸桿菌）合同製造市場：按方法，2017-2030

• 體內
• 離體

第 8 章全球 GMP 蛋白質（大腸桿菌）合同製造市場：按最終用戶分類，2017-2030

• 生物技術公司、製藥公司
• 學術和研究機構
• 委託研究機構
• 其他

第 9 章全球 GMP 蛋白質（大腸桿菌）合同製造市場：按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第10章競爭格局

• Merck & Co., Inc
• Thermo Fisher Scientific Inc.
• Abcam plc
• GenScript
• Biomay AG
• SOL GROUP
• Proteintech Group, Inc.
• Nordmark Pharma GmbH
• Sino Biological, Inc.
• Kaneka Eurogentec S.A.
• Abnova Corporation
• Eurofins Scientific
• Arcline Investment Management LP.
• Abgenex
• Xpress Biologics
• Avid Bioservices, Inc.
• Bio-Techne
• Northway Biotech
• Aldevron
• Institut Merieux
• PerkinElmer Inc.
• Creative BioMart
• Profacgen
• ProBioGen AG
• 53Biologics
• Leadgene Biomedical, Inc.
• Ajinomoto Bio-Pharma
• FUJIFILM Diosynth Biotechnologies
• Avioq, Inc
• Biovian Oy
• KBI Biopharma
• GTP Bioways
• QIAGEN
• Suzhou Novoprotein Technology Co., Ltd
• ACROBiosystems
• Kactus
• F. Hoffmann-La Roche Ltd.
• Enzo Life Sciences, Inc.

第 11 章章節

• 調查方法
• 關於出版商

GMP Protein (E. coli) may or may not be manufactured using animal-free processes depending on the characteristics of the protein. Recombinant Protein is a protein encoded by a gene recombinant DNA that has been cloned in a system that supports the expression of the gene and translation of messenger RNA. Modification of the gene by recombinant DNA technology can lead to the expression of a mutant protein. Proteins co-expressed in bacteria will not possess post-translational modifications, e.g. phosphorylation or glycosylation. Some of the recombinant proteins which were produced and commercialized in medications are Humulin, Hematrope, Avonex, Kogenate, Pulmozyme and others.

Market Dynamics

Increasing launches of products in the market is expected to drive the growth of the global GMP protein (E. coli) contract manufacturing market over the forecast period. For instance, in June 2022, AMSBIO, a provider of quality life science research reagents and services, announced the launch of its Stem Fit Protein range of recombinant proteins for cell therapy applications. The Stem Fit Protein range includes recombinant proteins that play key roles in differentiating Embryonic Stem (ES) and induced Pluripotent Cells (iPS) in the pancreas, heart, kidney, blood, and immune cells. Moreover, in September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom GMP grade recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.

Key features of the study:

• This report provides an in-depth analysis of the global GMP protein (E. coli) contract manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global GMP protein (E. coli) contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc., Thermo Fisher Scientific Inc., Abcam plc, GenScript, Biomay AG, SOL GROUP, Proteintech Group, Inc., Nordmark Pharma GmbH, Sino Biological, Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc, Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen, ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc, Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd., and Enzo Life Sciences, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global GMP protein (E. coli) contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP protein (E. coli) contract manufacturing market.

Detailed Segmentation:

• Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type:
  • Cytokines
  • Growth Factors
  • Enzymes
    • DNA polymerase
    • Protease
    • Trypsin
    • Nuclease
  • Benzonase
  • Cas9 Nucleases
  • Others
    • IVT Enzymes
    • Others
  • Hormones
  • Antigens
  • Others
• Global GMP Protein (E. coli) Contract Manufacturing Market, By Application:
  • Gene Therapy
  • Cell Therapy
• Global GMP Protein (E. coli) Contract Manufacturing Market, By Method:
  • In-Vivo
  • Ex-Vivo
• Global GMP Protein (E. coli) Contract Manufacturing Market, By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Others
• Global GMP Protein (E. coli) Contract Manufacturing Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Merck & Co., Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
  • Abcam plc
  • GenScript
  • Biomay AG
  • SOL GROUP
  • Proteintech Group, Inc.
  • Nordmark Pharma GmbH
  • Sino Biological, Inc.
  • Abnova Corporation
  • Eurofins Scientific
  • Arcline Investment Management LP
  • Abgenex
  • Xpress Biologics
  • Avid Bioservices Inc
  • Bio-Techne
  • Northway Biotech
  • Aldevron
  • Institut Merieux
  • PerkinElmer Inc.
  • Creative BioMart
  • Profacgen
  • ProBioGen AG
  • 53Biologics
  • Leadgene Biomedical, Inc.
  • Ajinomoto Bio-Pharma
  • FUJIFILM Diosynth Biotechnologies
  • Avioq, Inc
  • Biovian Oy
  • KBI Biopharma
  • GTP Bioways
  • QIAGEN
  • Suzhou Novoprotein Technology Co., Ltd.
  • ACROBiosystems
  • Kactus
  • F. Hoffmann-La Roche Ltd.
  • Enzo Life Sciences, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Method
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• PEST Analysis
• Porter's Analysis
• Key Developments
• Regulatory Scenario
• Acquisition and Agreement Scenario
• Brand Mapping

4. Global GMP Protein (E. coli) Contract Manufacturing Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cytokines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Growth Factors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Enzymes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• DNA polymerase
• Protease
• Trypsin
• Nuclease
  • Benzonase
  • Cas9 Nucleases
  • Others
• IVT Enzymes
• Others
• Hormones
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Antigens
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global GMP Protein (E. coli) Contract Manufacturing Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Gene Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cell Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global GMP Protein (E. coli) Contract Manufacturing Market, By Method, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• In-Vivo
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Ex-Vivo
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global GMP Protein (E. coli) Contract Manufacturing Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global GMP Protein (E. coli) Contract Manufacturing Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Merck & Co., Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Thermo Fisher Scientific Inc.
• Abcam plc
• GenScript
• Biomay AG
• SOL GROUP
• Proteintech Group, Inc.
• Nordmark Pharma GmbH
• Sino Biological, Inc.
• Kaneka Eurogentec S.A.
• Abnova Corporation
• Eurofins Scientific
• Arcline Investment Management LP.
• Abgenex
• Xpress Biologics
• Avid Bioservices, Inc.
• Bio-Techne
• Northway Biotech
• Aldevron
• Institut Merieux
• PerkinElmer Inc.
• Creative BioMart
• Profacgen
• ProBioGen AG
• 53Biologics
• Leadgene Biomedical, Inc.
• Ajinomoto Bio-Pharma
• FUJIFILM Diosynth Biotechnologies
• Avioq, Inc
• Biovian Oy
• KBI Biopharma
• GTP Bioways
• QIAGEN
• Suzhou Novoprotein Technology Co., Ltd
• ACROBiosystems
• Kactus
• F. Hoffmann-La Roche Ltd.
• Enzo Life Sciences, Inc.

11. Section

• Research Methodology
• About Us